Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
17.99
-0.04 (-0.19%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Phibro Animal Health stock have an average target of 21, with a low estimate of 15 and a high estimate of 25. The average target predicts an increase of 16.76% from the current stock price of 17.99.
Analyst Consensus: Sell
* Price targets were last updated on Feb 10, 2025.
Analyst Ratings
The average analyst rating for Phibro Animal Health stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 2 | 2 | 2 | 2 | 2 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Sell Maintains $20 → $22 | Sell | Maintains | $20 → $22 | +22.32% | Feb 10, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | +39.00% | Dec 17, 2024 |
Barclays | Barclays | Sell Maintains $13 → $20 | Sell | Maintains | $13 → $20 | +11.20% | Nov 12, 2024 |
JP Morgan | JP Morgan | Hold Initiates $22 | Hold | Initiates | $22 | +22.32% | Sep 10, 2024 |
B of A Securities | B of A Securities | Sell Maintains $13 → $15 | Sell | Maintains | $13 → $15 | -16.60% | Aug 30, 2024 |
Financial Forecast
Revenue This Year
1.30B
from 1.02B
Increased by 27.84%
Revenue Next Year
1.43B
from 1.30B
Increased by 10.22%
EPS This Year
1.98
from 0.06
Increased by 3,217.46%
EPS Next Year
2.19
from 1.98
Increased by 10.82%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.4B | 1.6B | 1.6B | ||
Avg | 1.3B | 1.4B | 1.5B | ||
Low | 1.2B | 1.3B | 1.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.3% | 19.4% | 11.3% | ||
Avg | 27.8% | 10.2% | 1.9% | ||
Low | 21.4% | -2.0% | -8.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.09 | 2.38 | 2.66 |
Avg | 1.98 | 2.19 | 2.39 |
Low | 1.86 | 1.98 | 2.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3,403.1% | 20.5% | 21.1% |
Avg | 3,217.5% | 10.8% | 8.8% |
Low | 3,021.6% | 0.0% | -3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.